Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Taylor G. Sandison, MD
Sponsor: Elion Therapeutics, Chief Medical Officer
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Az Sint-Jan Brugge
Bruges, Belgium
Recruiting - Universite Libre de Bruxelles (ulb) - Institut Jules Bordet
Brussels, Belgium
Recruiting - Uz Leuven
Leuven, Belgium
Recruiting
- Juravinski Hospital
Hamilton, Ontario, Canada
Recruiting
- Centre Hospitalier D'Argenteuil
Argenteuil, France
Recruiting - Ap-Hp Hopital Henri Modor
Créteil, France
Recruiting
- Istituto Europeo Di Oncologia
Milan, Italy
Recruiting - Fondazione Policlinico Universitario A. Gemelli Irccs- Universita Cattolica del Sacro Cuore
Roma, Italy
Recruiting
- Hospital Clinic Barcelona
Barcelona, Spain
Recruiting - Hospital Universitario Vall D'Hebron
Barcelona, Spain
Recruiting - Hospital del Mar
Barcelona, Spain
Recruiting - Hospital Clinico Universitario de Salamanca
Salamanca, Spain
Recruiting
- U. of Alabama at Birmingham
Birmingham, Alabama, United States
Recruiting - Uc Davis Medical Center
Sacramento, California, United States
Recruiting - Massachusetts General Hospital
Boston, Massachusetts, United States
Recruiting - U. of Michigan
Ann Arbor, Michigan, United States
Recruiting - Washington U.
St Louis, Missouri, United States
Recruiting - U. of Texas, Md Anderson
Houston, Texas, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Feb 2026
- Primary completion
- 31 Dec 2026
- Completion
- 31 Dec 2026
- Last update posted
- 8 Jul 2026
- Registered enrollment
- 60
- Registry id
- NCT07215273
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.